Fig. 4.

Final results of the voting on case scenario 3, severe psoriatic nail disease causing functional or emotional impairment. a denotes P < 0.05 compared with adalimumab therapy; b denotes P < 0.01 compared with infliximab therapy; c denotes P < 0.05 compared with etanercept therapy; d denotes P < 0.05 compared with MTX + TNFI therapy; e denotes P < 0.05 compared with TNFI-adalimumab preferred therapy. MTX methotrexate; pref preferred; TNFI tumor necrosis factor inhibitor